Lists

ASX announcements about tariff impacts


April 5, 2025

Donald Trump's big tariffs reveal rolled out at about 8am Australian time on April 3, after the US stockmarket had closed for the day. Here is how ASX listed companies responded via ASX announcements in the following days. Have written to Ansell requesting they join this list after the 14% slump in its share price on April 3.

April 3, 2025

8.37am Fisher & Paykel: health products manufacturing splits 45% Mexico and 55% New Zealand with 43% of revenue in latest half coming from US market.

8.38am Treasury Wine Estates: minimal impact given US division produced 35% of EBIT in latest half buy 85% of this is produced in the US and not subject to 10% tariff like the other $35m in sales from the latest half.

9.37am Cochlear: hearing implants have traditionally been exempt but we'll know if the 10% tariff applies when the US Customers and Border Protection Notice of Implementation is published in the next week.

9.58am Cettire: 41% of total sales are from European goods sold into US market. However, individual sales below $US800 will remain exempt and their average sale is $US514. Announcement failed to say what tariff was proposed by Trump. Didn't realise how much Europe dominates luxury goods manufacturing.

11.22am CSL: a skinny effort pointing out that "at this stage pharmaceutical products are not subject to reciprocal tariffs".

11.53am Breville: generates 45% of sales in the US and currently manufacturers 90% of its product in China but is looking to diversify in Mexico, Cambodia and Indonesia. No mention of manufacturing in the US.

April 4, 2025

7.31am Tourism Holdings Ltd: the Auckland-based company warned of lower sales and rentals of its tourism vehicles in the US.

9.29am Ansell: manufactures in 5 Asian countries and generates 43% of its revenue from the US. It has maintained guidance because it will pass on the tariffs and current on-shore US competition is "negligible". Stock fell 14% yesterday.

9.33am Mesoblast: updated that tariffs were unlikely to apply to its USD drug sales.

4.49pm ARB Corp: a bit of a nothing statement about exports from Thailand to the US.